Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Recruiting now

Conditions studied: Cachexia, Digestive System Cancer, Gastric Cancer, Colorectal Cancer, Hepatocellular Carcinoma

In brief

This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based therapy.

Key facts

Study ID
NCT06940102
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
People needed
120
Starts
2025-03-12
Expected to finish
2026-12-01
Last updated by the study team
2025-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.